CHP
NERV icon

Cable Hill Partners’s Minerva Neurosciences NERV Stock Holding History

Cable Hill Partners’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-125
Closed -$7K – 907
2018
Q1 		$7K Buy
+125
New +$6.01K ﹤0.01% 582

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IVAV
Index Venture Associates V St. Helier, Channel Islands, Jersey $1.46M AUM 88.05% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Cable Hill Partners's NERV Position: Q2 2018 in Review

Cable Hill Partners sold out of Minerva Neurosciences (NERV) in Q2 2018, closing a stake of 125 shares — an estimated $7K sold.

Cable Hill Partners first reported a position in NERV in Q1 2018 and held it in 1 quarter. The position peaked at $7K in Q1 2018. 73 funds tracked by Wall St. Rank hold NERV as of Q2 2018.

  • Cable Hill Partners reported no remaining Minerva Neurosciences position as of Q2 2018 after selling out during the quarter.
  • Cable Hill Partners sold 125 Minerva Neurosciences shares in Q2 2018, an estimated $7K.
  • Cable Hill Partners first reported a position in Minerva Neurosciences in Q1 2018 and held it in 1 quarter.
  • Cable Hill Partners's Minerva Neurosciences position peaked at $7K in Q1 2018.
  • 73 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2018.

Based on Cable Hill Partners's 13F filing for Q2 2018, filed 3 Aug 2018.